Table 1

Existing public databases with antibody sequences, structures and properties (data from May 2024).

NameDataDescriptionRef
AbDbSequence StructureExtract Fv regions from antibody structures using the SACS database, which provides a summary of antibody PDB structures.[37]
AB-BindStructureIncludes 1101 mutants with experimentally determined |$\Delta \Delta $|G changes in 32 complexes.[38]
AbDiverSequencesCollects data from 900M immunoglobulin sequences (81 studies) for diversity exploration via positional profiling, V-region searches and clonotype examination.[39]
abYsisSequence StructureBioinformatic tool perform various operations, including antibody sequence management, 3D structure integration, automated antibody numbering, canonical class annotation, unusual residue identification, humanization, germline view and user input.[36]
Cov-AbDabSequenceCatalogs 12 916 entries of published/patented antibodies and nanobodies that bind to coronaviruses, such as SARS-CoV2 and SARS-CoV1.[40]
INDISequence StructureIntegrates nanobody sequences, structures and the metadata associated with them from all the major data repositories in the public domain (e.g. PDB, patent and scientific publications).[41]
NanoLASSequence StructureUser-friendly nanobody information database that provides extensive and diverse data sources. It also offers intuitive 3D visualization of nanobody structures and a comparative analysis feature, making scientific research and understanding easier.[42]
OASSequenceHouses over 2 billion immune repertoires from 90 studies, including diverse immune states, organisms and individuals, with unpaired and paired antibody sequences.[43]
PADSequenceContains around 267 722 antibody chains sourced from primary patent documents and third-party patent documents.[44]
PLAbDabSequenceContains over 150 000 paired antibody sequences and 3D structural models from patent and academic papers.[45]
SAbDabStructureHouses annotated antibody structures from the PDB, offering a consistent presentation alongside experimental details, affinity data and sequence annotations.[46]
sdAb-DBSequencesCompiles single-domain antibody sequences from literature, online repositories (PDB and NCBI) and user contributions.[47]
SKEMPIStructureComprises thermodynamic and kinetic changes upon mutation in solved PPI complexes in the PDB.[48, 49]
Thera-SAbDabSequence StructureIncludes World Health Organization-recognized antibody and nanobody therapeutics, matching structures in SAbDab with nearly identical sequences or identical variable domain sequences.[50]
NameDataDescriptionRef
AbDbSequence StructureExtract Fv regions from antibody structures using the SACS database, which provides a summary of antibody PDB structures.[37]
AB-BindStructureIncludes 1101 mutants with experimentally determined |$\Delta \Delta $|G changes in 32 complexes.[38]
AbDiverSequencesCollects data from 900M immunoglobulin sequences (81 studies) for diversity exploration via positional profiling, V-region searches and clonotype examination.[39]
abYsisSequence StructureBioinformatic tool perform various operations, including antibody sequence management, 3D structure integration, automated antibody numbering, canonical class annotation, unusual residue identification, humanization, germline view and user input.[36]
Cov-AbDabSequenceCatalogs 12 916 entries of published/patented antibodies and nanobodies that bind to coronaviruses, such as SARS-CoV2 and SARS-CoV1.[40]
INDISequence StructureIntegrates nanobody sequences, structures and the metadata associated with them from all the major data repositories in the public domain (e.g. PDB, patent and scientific publications).[41]
NanoLASSequence StructureUser-friendly nanobody information database that provides extensive and diverse data sources. It also offers intuitive 3D visualization of nanobody structures and a comparative analysis feature, making scientific research and understanding easier.[42]
OASSequenceHouses over 2 billion immune repertoires from 90 studies, including diverse immune states, organisms and individuals, with unpaired and paired antibody sequences.[43]
PADSequenceContains around 267 722 antibody chains sourced from primary patent documents and third-party patent documents.[44]
PLAbDabSequenceContains over 150 000 paired antibody sequences and 3D structural models from patent and academic papers.[45]
SAbDabStructureHouses annotated antibody structures from the PDB, offering a consistent presentation alongside experimental details, affinity data and sequence annotations.[46]
sdAb-DBSequencesCompiles single-domain antibody sequences from literature, online repositories (PDB and NCBI) and user contributions.[47]
SKEMPIStructureComprises thermodynamic and kinetic changes upon mutation in solved PPI complexes in the PDB.[48, 49]
Thera-SAbDabSequence StructureIncludes World Health Organization-recognized antibody and nanobody therapeutics, matching structures in SAbDab with nearly identical sequences or identical variable domain sequences.[50]
Table 1

Existing public databases with antibody sequences, structures and properties (data from May 2024).

NameDataDescriptionRef
AbDbSequence StructureExtract Fv regions from antibody structures using the SACS database, which provides a summary of antibody PDB structures.[37]
AB-BindStructureIncludes 1101 mutants with experimentally determined |$\Delta \Delta $|G changes in 32 complexes.[38]
AbDiverSequencesCollects data from 900M immunoglobulin sequences (81 studies) for diversity exploration via positional profiling, V-region searches and clonotype examination.[39]
abYsisSequence StructureBioinformatic tool perform various operations, including antibody sequence management, 3D structure integration, automated antibody numbering, canonical class annotation, unusual residue identification, humanization, germline view and user input.[36]
Cov-AbDabSequenceCatalogs 12 916 entries of published/patented antibodies and nanobodies that bind to coronaviruses, such as SARS-CoV2 and SARS-CoV1.[40]
INDISequence StructureIntegrates nanobody sequences, structures and the metadata associated with them from all the major data repositories in the public domain (e.g. PDB, patent and scientific publications).[41]
NanoLASSequence StructureUser-friendly nanobody information database that provides extensive and diverse data sources. It also offers intuitive 3D visualization of nanobody structures and a comparative analysis feature, making scientific research and understanding easier.[42]
OASSequenceHouses over 2 billion immune repertoires from 90 studies, including diverse immune states, organisms and individuals, with unpaired and paired antibody sequences.[43]
PADSequenceContains around 267 722 antibody chains sourced from primary patent documents and third-party patent documents.[44]
PLAbDabSequenceContains over 150 000 paired antibody sequences and 3D structural models from patent and academic papers.[45]
SAbDabStructureHouses annotated antibody structures from the PDB, offering a consistent presentation alongside experimental details, affinity data and sequence annotations.[46]
sdAb-DBSequencesCompiles single-domain antibody sequences from literature, online repositories (PDB and NCBI) and user contributions.[47]
SKEMPIStructureComprises thermodynamic and kinetic changes upon mutation in solved PPI complexes in the PDB.[48, 49]
Thera-SAbDabSequence StructureIncludes World Health Organization-recognized antibody and nanobody therapeutics, matching structures in SAbDab with nearly identical sequences or identical variable domain sequences.[50]
NameDataDescriptionRef
AbDbSequence StructureExtract Fv regions from antibody structures using the SACS database, which provides a summary of antibody PDB structures.[37]
AB-BindStructureIncludes 1101 mutants with experimentally determined |$\Delta \Delta $|G changes in 32 complexes.[38]
AbDiverSequencesCollects data from 900M immunoglobulin sequences (81 studies) for diversity exploration via positional profiling, V-region searches and clonotype examination.[39]
abYsisSequence StructureBioinformatic tool perform various operations, including antibody sequence management, 3D structure integration, automated antibody numbering, canonical class annotation, unusual residue identification, humanization, germline view and user input.[36]
Cov-AbDabSequenceCatalogs 12 916 entries of published/patented antibodies and nanobodies that bind to coronaviruses, such as SARS-CoV2 and SARS-CoV1.[40]
INDISequence StructureIntegrates nanobody sequences, structures and the metadata associated with them from all the major data repositories in the public domain (e.g. PDB, patent and scientific publications).[41]
NanoLASSequence StructureUser-friendly nanobody information database that provides extensive and diverse data sources. It also offers intuitive 3D visualization of nanobody structures and a comparative analysis feature, making scientific research and understanding easier.[42]
OASSequenceHouses over 2 billion immune repertoires from 90 studies, including diverse immune states, organisms and individuals, with unpaired and paired antibody sequences.[43]
PADSequenceContains around 267 722 antibody chains sourced from primary patent documents and third-party patent documents.[44]
PLAbDabSequenceContains over 150 000 paired antibody sequences and 3D structural models from patent and academic papers.[45]
SAbDabStructureHouses annotated antibody structures from the PDB, offering a consistent presentation alongside experimental details, affinity data and sequence annotations.[46]
sdAb-DBSequencesCompiles single-domain antibody sequences from literature, online repositories (PDB and NCBI) and user contributions.[47]
SKEMPIStructureComprises thermodynamic and kinetic changes upon mutation in solved PPI complexes in the PDB.[48, 49]
Thera-SAbDabSequence StructureIncludes World Health Organization-recognized antibody and nanobody therapeutics, matching structures in SAbDab with nearly identical sequences or identical variable domain sequences.[50]
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close